CoChat

Molecular Insight into the Therapeutic Promise of Targeting APOE4 for Alzheimer’s Disease

Open access
Mamun, Abdullah Al, Uddin, Md. Sahab, Bin Bashar, Md. Fahim, Zaman, Sonia, Begum, Yesmin, Bulbul, Israt Jahan, Islam, Md. Siddiqul, Sarwar, Md. Shahid, Mathew, Bijo, Amran, Md. Shah, Md Ashraf, Ghulam, Bin-Jumah, May N., Mousa, Shaker A., Abdel-Daim, Mohamed M. · 2020 · Oxidative Medicine and Cellular Longevity
Cited by 53

The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.

Abstract

Alzheimer’s disease (AD) is a progressive neurodegenerative disease that causes chronic cognitive dysfunction. Most of the AD cases are late onset, and the apolipoprotein E (APOE) isoform is a key genetic risk factor. The APOE gene has 3 key alleles in humans including APOE2,APOE3, and APOE4. Among them,APOE4 is the most potent genetic risk factor for late-onset AD (LOAD), while APOE2 has a defensive effect. Research data suggest that APOE4 leads to the pathogenesis of AD through various processes such as accelerated beta-amyloid aggregations that raised neurofibrillary tangle formation, cerebrovascular diseases, aggravated neuroinflammation, and synaptic loss. However, the precise mode of actions regarding in what way APOE4 leads to AD pathology remains unclear. Since APOE contributes to several pathological pathways of AD, targeting APOE4 might serve as a promising strategy for the development of novel drugs to combat AD. In this review, we focus on the recent studies about APOE4-targeted therapeutic strategies that have been advanced in animal models and are being prepared for use in humans for the management of AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2020/5086250

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 88 references

Cited by

See all 53

Metadata

Authors
Mamun, A. A., Uddin, M. S., Bin Bashar, M. F., Zaman, S., Begum, Y., Bulbul, I. J., Islam, M. S., Sarwar, M. S., Mathew, B., Amran, M. S., Md Ashraf, G., Bin-Jumah, M. N., Mousa, S. A., & Abdel-Daim, M. M.
Venue
Oxidative Medicine and Cellular Longevity
Publisher
Wiley
Published
2020-05-15
Volume
2020
Pages
1-16
ISSN
  • 1942-0994 (ISSN-L)
  • 1942-0900
OpenAlex
W3025352529
Cited by
53
References
88
FWCI
4.65
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Molecular Insight into the Therapeutic Promise of Targeting APOE4 for Alzheimer’s Disease. https://app.cochat.ai/papers/10.1155/2020/5086250
The paper
Mamun, A. A., Uddin, M. S., Bin Bashar, M. F., Zaman, S., Begum, Y., Bulbul, I. J., Islam, M. S., Sarwar, M. S., Mathew, B., Amran, M. S., Md Ashraf, G., Bin-Jumah, M. N., Mousa, S. A., & Abdel-Daim, M. M. (2020). Molecular Insight into the Therapeutic Promise of Targeting APOE4 for Alzheimer’s Disease. Oxidative Medicine and Cellular Longevity. https://doi.org/10.1155/2020/5086250

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.